Abstract：Objective To compare the dosimetric difference between volumetric modulated arc therapy (VMAT) and static intensity modulated radiotherapy (IMRT) for esophageal carcinoma. Methods Thirty patients were selected in this study, including 5 cases in the cervical, 5 the lower thorax, 10 the upper thorax and 10 the middle thorax. VMAT plans with a single arc and IMRT plans with five fields designed for each patients. Planning target volume (PTV) were prescribed to 60 Gy in 30 fractions. Delta 4 was used to verifie the dosimetric of treatment plans. Using paired t-test or Wilcoxon signed-test to compare the dose distribution on planning and organs at risk (OAR). The monitor units and treatment time were also evaluated to measure the treatment efficiency. Results All the VMAT and IMRT plans can satisfy the clinical dosimetry requirements. VMAT had better conformal index for PTV than IMRT (P=0.008). VMAT was better than IMRT by reducing the Dmax of spinal cord (P=0.032),while the V30,V40 and Dmean of heart were significantly higher (P=0.041,0.012,0.002).For cervicals, the V5, V10, V15 and mean dose of lung were significant higher in VMAT than those in IMRT (P=0.002- 0.002,0.002). For uppers, the values of heart V30 and Dmean were significantly larger in VMAT than IMRT (P=0.030,0.026). However, the Dmax of spinal cord in VMAT was lower than IMRT (P=0.006). For middles, VMAT reduced V10, V15, V20 of lung (P=0.015,0.028,0.041). There were no significant differences between VMAT and IMRT in the lowers (P=0.262- 0.998). The 3 mm/3% γ pass rate was 92.75% for VMAT and 92.98% for IMRT (P=0.826). The average MU of VMAT (460.66 MU) was reduced by 11.84%compared with IMRT (522.55 MU)(P=0.001). The delivery time of VMAT (139.6 s)compared with IMRT (298.73 s) was reduced by an average of 53.27%(P=0.000). ConclusionsCompared with IMRT, VMAT improved the OARs dose sparing and the target CI with similar dose distribution to the target. VMAT required fewer MU, shorten the treatment time significantly. The implementation of Synergy is stable and reliable.
Liu Lihong,Wang Lan,Han Chun et al. The application of volumetric modulated arc therapy in esophageal carcinoma[J]. Chinese Journal of Radiation Oncology, 2015, 24(3): 318-321.
[1] 钱立庭,杨伟志,刘新帆.模拟IMRT模式的生物效应研究初探[J].中华放射肿瘤学杂志,2005,14(5):431-434. [2] Wang JZ, Li XA,D′Souza WD, et al. Impact of prolonged fraction delivery times on tumor control probability:a note of caution for IMRT[J]. Int J Radiat Oncol Biol Phys,2003,57(2):543-552. [3] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001. [4] Feuvret L, Nol G, Mazeron JJ, et al. Conformity index:a review[J]. Int J Radiat Oncol Biol Phys,2006,64(2):333-342. [5] Wolff D,Stieler F,Welzel G,et al. Volumetric modulated arc therapy (VMAT) vs.serial tomotherapy,step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer[J].Radiother Oncol,2009,93(2):226-233.DOI:10.1016/j.radonc.2009.08.011. [6] Wagner D, Christiansen H, Wolff H, et al. Radiotherapy of malignant gliomas:comparison of volumetric single arc technique (RapidArc),dynamic intensity-modulated technique and 3D conformal technique[J].Radiother Oncol,2009,93(3):593-596.DOI:10.1016/j.radonc.2009.10.002. [7] Bertelsen A, Hansen CR, Johansen J, et al. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer[J]. Radiother Oncol,2010,95(2):142-148.DOI:10.1016/j.radonc.2010.01.011. [8] Hope AJ, Lindsay PE, El Naga I, et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters[J]. Int J Radiat Oncol Biol Phys,2006,65(1):112-124. [9] Marks LB, Spencer DP, Sherouse GW, et a1. The role of three dimensional functional lung in radiation treatment planning:the functional dose-volume histogram[J]. Int J Radiat Oncol Biol Phys,1995,33(1):65-75. [10] 王澜,李晓宁,吕冬婕,等.肺低剂量区体积预测急性放射性肺炎价值探讨[J].中华放射肿瘤学杂志,2010,19(4):296-300.DOI:10.3760/cma.j.issn.1004-4221.2010.04.005. [11] 刘晓静,张西志,李峻,等.胸中段食管癌旋转容积调强与固定野动态调强放疗的剂量学研究[J].实用癌症杂志,2011,26(6):630-633.DOI:10.3969/j.issn.1001-5930.2011.06.025. [12] Yin L, Wu H, Gong J, et al. Volumetric-modulated arc therapy vs c-IMRT in esophageal cancer:a treatment planning comparison[J]. World J Gastroenterol,2012,18(37):5266-5275.DOI:10.3748/wjg.v18.i37.5266. [13] Clivio A, Fogliata A, Franzetti-Pellanda A, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal:a treatment planning comparison with fixed field IMRT[J]. Radiother Oncol,2009,92(1):118-124.DOI:10.1016/j.radonc.2008.12.020.
2015, Vol. 24 
